Literature DB >> 31638739

5-Aminolevulinic Acid-Loaded Hyaluronic Acid Dissolving Microneedles for Effective Photodynamic Therapy of Superficial Tumors with Enhanced Long-Term Stability.

Jinjin Zhu1, Liyun Dong1, Hongyao Du1, Jinzhu Mao1, Ying Xie1, Hua Wang2, Jiajia Lan1, Yuchen Lou1, Yangxue Fu1, Jingjing Wen1, Biling Jiang1, Yuce Li2, Jintao Zhu2, Juan Tao1.   

Abstract

5-Aminolevulinic acid (5-ALA) is one of the most widely used prodrug in clinical photodynamic therapy of dermatological diseases and cancers; yet, its clinical application is still limited by the shallow skin penetration and unsatisfied stability in any existed formulations. Here, 5-ALA-loaded hyaluronic acid dissolving microneedles (5-ALA@HAMNs) are prepared for photodynamic therapy of superficial tumors. The HAMNs can not only assist the loaded 5-ALA to effectively penetrate the stratum corneum but also provide 5-ALA with an acidic and oxygen-free environment to reduce the dimerization of 5-ALA molecules via Schiff-base bonds and formation of inactive pyrazine derivatives, thus maintaining its chemical structure and biological activity. The chemical stability of 5-ALA in HAMNs is confirmed by UV-vis spectra and mass spectra measurements. The 5-ALA@HAMNs display remarkable tumor elimination both in vitro and in vivo, even after storage at room temperature for nine months, making it a highly potential device for effective delivery of 5-ALA in cancer photodynamic therapy.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  5-aminolevulinic acid; dissolving microneedles; long-term stability; photodynamic therapy; superficial tumors

Year:  2019        PMID: 31638739     DOI: 10.1002/adhm.201900896

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  7 in total

1.  "Pincer movement": Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles.

Authors:  Boyi Niu; Yixian Zhou; Kaixin Liao; Ting Wen; Sixian Lao; Guilan Quan; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2021-10-21       Impact factor: 14.903

Review 2.  Microneedles: a potential strategy in transdermal delivery and application in the management of psoriasis.

Authors:  Zihan Zhao; Youdong Chen; Yuling Shi
Journal:  RSC Adv       Date:  2020-04-07       Impact factor: 4.036

Review 3.  Microneedles in Action: Microneedling and Microneedles-Assisted Transdermal Delivery.

Authors:  Dong-Jin Lim; Hong-Jun Kim
Journal:  Polymers (Basel)       Date:  2022-04-15       Impact factor: 4.967

Review 4.  Recent Advancements in Microneedle Technology for Multifaceted Biomedical Applications.

Authors:  Deepak Kulkarni; Fouad Damiri; Satish Rojekar; Mehrukh Zehravi; Sarker Ramproshad; Dipali Dhoke; Shubham Musale; Ashiya A Mulani; Pranav Modak; Roshani Paradhi; Jyotsna Vitore; Md Habibur Rahman; Mohammed Berrada; Prabhanjan S Giram; Simona Cavalu
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525

Review 5.  Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges.

Authors:  Fouad Damiri; Nagavendra Kommineni; Samuel Ogbeide Ebhodaghe; Raviteja Bulusu; Vaskuri G S Sainaga Jyothi; Amany A Sayed; Aeshah A Awaji; Mousa O Germoush; Hamdan S Al-Malky; Mohammed Z Nasrullah; Md Habibur Rahman; Mohamed M Abdel-Daim; Mohammed Berrada
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-03

6.  Microneedle Patches with O2 Propellant for Deeply and Fast Delivering Photosensitizers: Towards Improved Photodynamic Therapy.

Authors:  Pei Liu; Yangxue Fu; Fulong Wei; Teng Ma; Jingli Ren; Zhanjun Xie; Shanzheng Wang; Jinjin Zhu; Lianbin Zhang; Juan Tao; Jintao Zhu
Journal:  Adv Sci (Weinh)       Date:  2022-07-15       Impact factor: 17.521

Review 7.  The most promising microneedle device: present and future of hyaluronic acid microneedle patch.

Authors:  Huizhi Kang; Zhuo Zuo; Ru Lin; Muzi Yao; Yang Han; Jing Han
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.